tm logo
THUZIUM
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 25 Jan 2024

Last Applicant/ Owned by

GSK Medicines Research Centre

Stevenage SG1

GB

SG12NY

Serial Number

97239287 filed on 26th Jan 2022

Registration Number

N/A

Correspondent Address

Christopher M. Hanes

GSK

410 Blackwell Street

Legal Brand Protection

Durham,NC 27701

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

THUZIUM

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiraRead More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Mark Details


Serial Number

No 97239287

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84051399

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25th Jan 2024SOU TEAS EXTENSION RECEIVED
25th Jan 2024SOU EXTENSION 2 FILED
25th Jan 2024SOU EXTENSION 2 GRANTED
18th Jul 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Jul 2023SOU TEAS EXTENSION RECEIVED
14th Jul 2023SOU EXTENSION 1 FILED
14th Jul 2023SOU EXTENSION 1 GRANTED
07th Feb 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13th Dec 2022PUBLISHED FOR OPPOSITION